R.E. Rose

2.3k total citations
18 papers, 1.7k citations indexed

About

R.E. Rose is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, R.E. Rose has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in Virology. Recurrent topics in R.E. Rose's work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (5 papers) and Hepatitis B Virus Studies (5 papers). R.E. Rose is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (5 papers) and Hepatitis B Virus Studies (5 papers). R.E. Rose collaborates with scholars based in United States, Australia and Philippines. R.E. Rose's co-authors include Richard J. Colonno, Luca Comai, Steven M. LeVine, Steven P. Weinheimer, William R. Hiatt, Daniel J. Tenney, Kevin A. Pokornowski, Gregory A. Thompson, David M. Stalker and Daniel Facciotti and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

R.E. Rose

18 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.E. Rose United States 15 802 732 444 418 273 18 1.7k
Lillian Chau United States 15 180 0.2× 48 0.1× 219 0.5× 622 1.5× 12 0.0× 19 1.0k
Angela Tafaro Italy 15 110 0.1× 33 0.0× 111 0.3× 252 0.6× 35 0.1× 27 737
Mingwei Tong China 15 189 0.2× 74 0.1× 185 0.4× 334 0.8× 5 0.0× 34 783
Iwona Bukowska‐Ośko Poland 15 285 0.4× 154 0.2× 162 0.4× 215 0.5× 27 0.1× 38 928
Balwan Singh United States 21 292 0.4× 9 0.0× 277 0.6× 419 1.0× 53 0.2× 65 1.5k
E. Falcone Italy 19 272 0.3× 37 0.1× 407 0.9× 497 1.2× 38 0.1× 45 1.3k
Yeneneh Haileselassie United States 14 155 0.2× 31 0.0× 139 0.3× 537 1.3× 3 0.0× 19 957
M. Kristina Hamilton United States 14 117 0.1× 7 0.0× 96 0.2× 550 1.3× 31 0.1× 17 963
Ben Meijer Netherlands 13 61 0.1× 27 0.0× 87 0.2× 471 1.1× 6 0.0× 20 771
Michele M. Tavernini Canada 10 197 0.2× 29 0.0× 178 0.4× 583 1.4× 2 0.0× 22 1.2k

Countries citing papers authored by R.E. Rose

Since Specialization
Citations

This map shows the geographic impact of R.E. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.E. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.E. Rose more than expected).

Fields of papers citing papers by R.E. Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.E. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.E. Rose. The network helps show where R.E. Rose may publish in the future.

Co-authorship network of co-authors of R.E. Rose

This figure shows the co-authorship network connecting the top 25 collaborators of R.E. Rose. A scholar is included among the top collaborators of R.E. Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.E. Rose. R.E. Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Barrett, Jacqueline S., Richard B. Gearry, Jane G. Muir, et al.. (2010). Dietary poorly absorbed, short‐chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Alimentary Pharmacology & Therapeutics. 31(8). 874–882. 294 indexed citations
2.
Tenney, Daniel J., Kevin A. Pokornowski, R.E. Rose, et al.. (2009). 20 ENTECAVIR MAINTAINS A HIGH GENETIC BARRIER TO HBV RESISTANCE THROUGH 6 YEARS IN NAIVE PATIENTS. Journal of Hepatology. 50. S10–S10. 55 indexed citations
3.
Rose, R.E., et al.. (2008). Entecavir at Five Years Shows Long-Term Maintenance of High Genetic Barrier to Hepatitis B Virus Resistance. Zeitschrift für Gastroenterologie. 46(9). 45 indexed citations
4.
Rose, R.E., et al.. (2007). [781] FOUR YEAR ASSESSMENT OF ETV RESISTANCE IN NUCLEOSIDE-NAIVE AND LAMIVUDINE REFRACTORY PATIENTS. Journal of Hepatology. 46. S294–S294. 82 indexed citations
5.
Miller, James F., Raymond L. Ethington, & R.E. Rose. (2006). Stratigraphic Implications of Lower Ordovician Conodonts from the Munising and Au Train Formations at Pictured Rocks National Lakeshore, Upper Peninsula of Michigan. Palaios. 21(3). 227–237. 3 indexed citations
6.
Colonno, Richard J., R.E. Rose, Carl J. Baldick, et al.. (2006). 490 High barrier to resistance results in no emergence of entecavir resistance in nucleoside-naïve subjects during the first two years of therapy. Journal of Hepatology. 44. S182–S182. 15 indexed citations
8.
Tenney, Daniel J., Steven M. LeVine, R.E. Rose, et al.. (2004). Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine. Antimicrobial Agents and Chemotherapy. 48(9). 3498–3507. 411 indexed citations
9.
LeVine, Steven M., Dennis Hernandez, Gregory Yamanaka, et al.. (2002). Efficacies of Entecavir against Lamivudine-Resistant Hepatitis B Virus Replication and Recombinant Polymerases In Vitro. Antimicrobial Agents and Chemotherapy. 46(8). 2525–2532. 146 indexed citations
10.
Rose, R.E., Ying Gong, Clifford Bechtold, et al.. (1996). Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.. Proceedings of the National Academy of Sciences. 93(4). 1648–1653. 99 indexed citations
11.
Lin, P F, Himadri Samanta, Clifford Bechtold, et al.. (1996). Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor. Antimicrobial Agents and Chemotherapy. 40(1). 133–138. 39 indexed citations
12.
Patick, Amy K., R.E. Rose, Clifford Bechtold, et al.. (1995). Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor. Journal of Virology. 69(4). 2148–2152. 51 indexed citations
13.
Lin, P F, Himadri Samanta, R.E. Rose, et al.. (1994). Genotypic And Phenotypic Analysis Of Human Immunodeficiency Virus Type 1 Isolates From Patients On Prolonged Stavudine Therapy. The Journal of Infectious Diseases. 170(5). 1157–1164. 108 indexed citations
14.
Samanta, Himadri, R.E. Rose, Amy K. Patick, et al.. (1994). Characterization of a Mutant HIV-1 Reverse Transcriptase Resistant to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)-imidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150). Antiviral chemistry & chemotherapy. 5(4). 278–281. 3 indexed citations
15.
Koning, Ann J., R.E. Rose, & Luca Comai. (1992). Developmental Expression of Tomato Heat-Shock Cognate Protein 80. PLANT PHYSIOLOGY. 100(2). 801–811. 56 indexed citations
16.
Smolik, Sarah M., R.E. Rose, & Richard H. Goodman. (1992). A cyclic AMP-responsive element-binding transcriptional activator in Drosophila melanogaster, dCREB-A, is a member of the leucine zipper family.. Molecular and Cellular Biology. 12(9). 4123–4131. 71 indexed citations
17.
Shewmaker, Christine K., et al.. (1990). Nucleotide sequence of an EF-1α genomic clone from tomato. Nucleic Acids Research. 18(14). 4276–4276. 30 indexed citations
18.
Comai, Luca, Daniel Facciotti, William R. Hiatt, et al.. (1985). Expression in plants of a mutant aroA gene from Salmonella typhimurium confers tolerance to glyphosate. Nature. 317(6039). 741–744. 227 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026